| LONZA N | 575.60 / +0.31% |
| Date/Time | 03/01 / 17:31 |
| Chg. / Chg.(%) | 1.80 / +0.31% |
| Bid | - / 39 |
| Ask | - / 2 |
| Open | 581.80 |
| Previous Close | 573.80 |
| High | 584.80 |
| Low | 572.80 |
| Volume [CHF] | 132,475,937.20 |
| Volume [Units] | 229,696 |
| Price fixings | 6188 |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 575.60 |  |
229,696 |
| London Inter.. | 576.05 |  |
18,763 |
| Cboe Europe .. | 576.20 | |
16,825 |
| Cboe Europe .. | 575.60 | |
15,524 |
| Turquoise | 576.00 | |
5,282 |
| Nasdaq Other.. | 633.3090 | |
24 |
| Lang & Schwa.. | 522.200 | |
|
| Mexico | 13,449.09 |  |
290 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
12/16/2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
12/07/2020 / 22:05 - GlobeNewswire
Real-time